These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23395350)

  • 1. Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs?
    Hamid H; Kanner AM
    Epilepsy Behav; 2013 Mar; 26(3):261-5. PubMed ID: 23395350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?
    Cardamone L; Salzberg MR; O'Brien TJ; Jones NC
    Br J Pharmacol; 2013 Apr; 168(7):1531-54. PubMed ID: 23146067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which SSRI is safest for patients with CVD and major depressive disorder?
    Dunham S; Wilkening GL; Schwier NC
    JAAPA; 2021 Apr; 34(4):18-19. PubMed ID: 33735134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can selective serotonin reuptake inhibitors/serotonin and norepinephrine reuptake inhibitor antidepressants decrease the "cytokine storm" in the course of COVID-19 pneumonia?
    Fei L; Santarelli G; D'Anna G; Moretti S; Mirossi G; Patti A; Sanfilippo G; Almerigogna F; Berni A; Caldini E; Lagi F; Para O; Vaudo M; Vultaggio A
    Panminerva Med; 2023 Sep; 65(3):321-326. PubMed ID: 34240839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SSRIs in the course of COVID-19 pneumonia: Evidence of effectiveness of antidepressants on acute inflammation. A retrospective study.
    Fei L; Bozza B; Melani G; Righi L; Santarelli G; Boy OB; Benedetti D; Falone A; Flaccomio D; Giuranno G; Martelli M; Merola P; Moretti S; Ndoci E; Pecoraro V; Siviglia S; Berni A; Fanelli A; Giovagnini E; Morettini A; Nozzoli C; Para O; Rostagno C; Tozzetti C
    Hum Psychopharmacol; 2024 Jan; 39(1):e2887. PubMed ID: 38059650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based medicine: are SSRIs more effective than placebo and what length of therapy is enough?
    Curtiss FR
    J Manag Care Pharm; 2005 Mar; 11(2):172-6, 177-8. PubMed ID: 15766323
    [No Abstract]   [Full Text] [Related]  

  • 7. Seizure Reduction with Fluoxetine in Dravet Syndrome.
    Meador KJ
    Epilepsy Behav Case Rep; 2014 Jan; 2():54-56. PubMed ID: 24955329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulation of sarco(endo)plasmic reticulum calcium-ATPases (SERCA).
    Stammers AN; Susser SE; Hamm NC; Hlynsky MW; Kimber DE; Kehler DS; Duhamel TA
    Can J Physiol Pharmacol; 2015 Oct; 93(10):843-54. PubMed ID: 25730320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extending the use of stiripentol to other epileptic syndromes: a case of PCDH19-related epilepsy.
    Trivisano M; Specchio N; Vigevano F
    Eur J Paediatr Neurol; 2015 Mar; 19(2):248-50. PubMed ID: 25510386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SERCA2a stimulation by istaroxime: a novel mechanism of action with translational implications.
    Huang CL
    Br J Pharmacol; 2013 Oct; 170(3):486-8. PubMed ID: 23822610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Istaroxime stimulates SERCA2a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition.
    Ferrandi M; Barassi P; Tadini-Buoninsegni F; Bartolommei G; Molinari I; Tripodi MG; Reina C; Moncelli MR; Bianchi G; Ferrari P
    Br J Pharmacol; 2013 Aug; 169(8):1849-61. PubMed ID: 23763364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reintroducing Fenfluramine as a Treatment for Seizures: Current Knowledge, Recommendations and Gaps in Understanding.
    Dini G; Di Cara G; Ferrara P; Striano P; Verrotti A
    Neuropsychiatr Dis Treat; 2023; 19():2013-2025. PubMed ID: 37790801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nationwide study of initiation of antidepressant pharmacotherapy and the risk of seizures.
    Wiggs KK; Lagerberg T; Quinn PD; Öberg AS; Larsson H; Chang Z; D'Onofrio BM
    Epilepsy Res; 2023 May; 192():107134. PubMed ID: 37037097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A unified hypothesis of SUDEP: Seizure-induced respiratory depression induced by adenosine may lead to SUDEP but can be prevented by autoresuscitation and other restorative respiratory response mechanisms mediated by the action of serotonin on the periaqueductal gray.
    Faingold CL; Feng HJ
    Epilepsia; 2023 Apr; 64(4):779-796. PubMed ID: 36715572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenfluramine: A Review of Pharmacology, Clinical Efficacy, and Safety in Epilepsy.
    Samanta D
    Children (Basel); 2022 Aug; 9(8):. PubMed ID: 36010049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant Drugs for Seizures and Epilepsy: Where do we Stand?
    Tallarico M; Pisano M; Leo A; Russo E; Citraro R; De Sarro G
    Curr Neuropharmacol; 2023; 21(8):1691-1713. PubMed ID: 35761500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suicidality in Patients With Epilepsy: Why Should Neurologists Care?
    Kanner AM
    Front Integr Neurosci; 2022; 16():898547. PubMed ID: 35712347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous and exogenous serotonin, but not sumatriptan, ameliorate seizures and neuroinflammation in the pentylenetetrazole-induced seizure model in rats.
    Torun IE; Kılınc YB; Kilinc E
    Arq Neuropsiquiatr; 2022 Jan; 80(1):48-55. PubMed ID: 35239805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lorcaserin for Dravet Syndrome: A Potential Advance Over Fenfluramine?
    Bialer M; Perucca E
    CNS Drugs; 2022 Feb; 36(2):113-122. PubMed ID: 35094259
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.